Haleon sees higher sales in 2024 as FY profits come in flat
Haleon
380.40p
09:35 23/12/24
-0.18%
-0.70p
Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.
FTSE 100
8,088.81
09:35 23/12/24
n/a
n/a
FTSE 350
4,463.62
09:35 23/12/24
n/a
n/a
FTSE All-Share
4,421.30
09:35 23/12/24
n/a
n/a
Pharmaceuticals & Biotechnology
19,928.24
09:34 23/12/24
0.85%
167.12
The maker of Panadol pain relief, spun out of pharma giant GSK in 2022, posted pre-tax profits of £1.62bn for 2023, up 0.6%. It now expects revenue to rise 4% - 6% this year.
Revenue grew 4.1% to £11.3bn.
Reporting by Frank Prenesti for Sharecast.com